Enrique Espinosa
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 75
- Cancer Immunotherapy and Biomarkers 20
- CAR-T cell therapy research 18
- Cutaneous Melanoma Detection and Management 15
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 12
-
- Melanoma and MAPK Pathways 26
- Co-authors
- Jaime Feliú (56 shared papers)Manuel González Barón (27 shared papers)Pilar Zamora (39 shared papers)Juan Ángel Fresno Vara (39 shared papers)Manuel González-Barón (16 shared papers)Andrés Redondo (25 shared papers)Angelo Gámez‐Pozo (30 shared papers)A Rappelli (3 shared papers)
- Journals
- Annals of Oncology (22 papers)Journal of Clinical Oncology (19 papers)Clinical & Translational Oncology (18 papers)PLoS ONE (8 papers)Cancer Research (7 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Enrique Espinosa
209 papers receiving 3.9k citations
Enrique Espinosa's Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 1.4k
- Cancer Research 502
- Ophthalmology 256
- Immunology 388
- Molecular Biology 1.3k
Countries citing papers authored by Enrique Espinosa
This map shows the geographic impact of Enrique Espinosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Espinosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Espinosa more than expected).
Fields of papers citing papers by Enrique Espinosa
This network shows the impact of papers produced by Enrique Espinosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Espinosa. The network helps show where Enrique Espinosa may publish in the future.
Co-authors
The 25 scholars most cited alongside Enrique Espinosa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 207 | |
| 2 | 2014 | 206 | |
| 3 | Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402) Hit paper breakdown → | 2021 | 155 |
| 4 | 2005 | 145 | |
| 5 | 2004 | 145 | |
| 6 | 2003 | 134 | |
| 7 | 1995 | 109 | |
| 8 | 2011 | 86 | |
| 9 | 2009 | 77 | |
| 10 | 2009 | 74 | |
| 11 | 1996 | 74 | |
| 12 | 2011 | 73 | |
| 13 | 2013 | 70 | |
| 14 | 1995 | 65 | |
| 15 | 2012 | 65 | |
| 16 | 1999 | 58 | |
| 17 | 2002 | 53 | |
| 18 | 1997 | 53 | |
| 19 | 2019 | 52 | |
| 20 | 2010 | 52 |
About Enrique Espinosa
Enrique Espinosa is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 221 papers that have together received 4.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (26 papers), Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (18 papers), Cutaneous Melanoma Detection and Management (15 papers), Ocular Oncology and Treatments (14 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (502 citations), Ophthalmology (256 citations), Immunology (388 citations) and Molecular Biology (1.3k citations). Enrique Espinosa has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Jaime Feliú, Manuel González Barón, Pilar Zamora, Juan Ángel Fresno Vara, Manuel González-Barón, Andrés Redondo, Angelo Gámez‐Pozo, A Rappelli, Paolo Dessı̀-Fulgheri and Salvador Martín‐Algarra. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical & Translational Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.